Cover Image

Development and implementation of a strategy for intensified screening for gambiense human African trypanosomiasis in Kongo Central province, DRC.

<h4>Background</h4>The Democratic Republic of the Congo (DRC) accounts for the majority of the reported gambiense human African trypanosomiasis (HAT) cases. Kongo Central province in the DRC reports a relatively low, yet steady number of cases, and forms a transboundary focus with Angola...

Full description

Saved in:

Bibliographic Details
Main Authors:	Crispin Lumbala (Author), Simon Kayembe (Author), Jacquies Makabuza (Author), Pascal Lutumba (Author), Jean-Pierre Van Geertruyden (Author), Paul R Bessell (Author), Joseph Mathu Ndung'u (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2020-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens.
by: Crispin Lumbala, et al.
Published: (2018)

Performance evaluation of a prototype rapid diagnostic test for combined detection of gambiense human African trypanosomiasis and malaria.
by: Crispin Lumbala, et al.
Published: (2020)

A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC.
by: Ching-I Huang, et al.
Published: (2023)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC.
by: Ronald E Crump, et al.
Published: (2022)

Abortion care availability, readiness, and access: linking population and health facility data in Kinshasa and Kongo Central, DRC
by: Sophia Magalona, et al.
Published: (2023)

Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study.
by: Sylvie Bisser, et al.
Published: (2016)

Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad
by: Kat S. Rock, et al.
Published: (2022)

Village-scale persistence and elimination of gambiense human African trypanosomiasis.
by: Christopher N Davis, et al.
Published: (2019)

Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis.
by: Francesco Checchi, et al.
Published: (2011)

Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis.
by: Pere P Simarro, et al.
Published: (2015)

Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC).
by: María Soledad Castaño, et al.
Published: (2020)

First WHO meeting of stakeholders on elimination of gambiense Human African Trypanosomiasis.
by: Peter Holmes
Published: (2014)

Syndromic algorithms for detection of gambiense human African trypanosomiasis in South Sudan.
by: Jennifer J Palmer, et al.
Published: (2013)

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with "screen, diagnose and treat" using innovative tools and strategies.
by: Joseph Mathu Ndung'u, et al.
Published: (2020)

Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad.
by: Marina Antillon, et al.
Published: (2023)

Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis.
by: Gerardo Priotto, et al.
Published: (2012)

The impact of vector migration on the effectiveness of strategies to control gambiense human African trypanosomiasis.
by: Martial L Ndeffo-Mbah, et al.
Published: (2019)

The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis.
by: Francesco Checchi, et al.
Published: (2018)

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis.
by: Michael P Barrett
Published: (2018)

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach.
by: Dramane Kaba, et al.
Published: (2023)

The burden of human African trypanosomiasis.
by: Eric M Fèvre, et al.
Published: (2008)

Prevalence of dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis in Guinea.
by: Alseny M'mah Soumah, et al.
Published: (2024)

The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
by: Andrew P Jackson, et al.
Published: (2010)

Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis.
by: Jeremy M Sternberg, et al.
Published: (2014)

Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T. b. gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa
by: Truc Philippe, et al.
Published: (2002)

Improved Access to Diagnostics for Rhodesian Sleeping Sickness around a Conservation Area in Malawi Results in Earlier Detection of Cases and Reduced Mortality
by: Marshal Lemerani, et al.
Published: (2020)

Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment.
by: Johannes A Blum, et al.
Published: (2009)

Innovative digital technologies for quality assurance of diagnosis of human African trypanosomiasis.
by: Epco Hasker, et al.
Published: (2018)

Specificity of serological screening tests and reference laboratory tests to diagnose gambiense human African trypanosomiasis: a prospective clinical performance study
by: Martial Kassi N'Djetchi, et al.
Published: (2024)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection.
by: Ipos Ngay Lukusa, et al.
Published: (2021)

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
by: Victor Kande Betu Ku Mesu, DPH, et al.
Published: (2021)

Metabolomics Identifies Multiple Candidate Biomarkers to Diagnose and Stage Human African Trypanosomiasis.
by: Isabel M Vincent, et al.
Published: (2016)

A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
by: Alexandre Hainard, et al.
Published: (2009)

Kenya Trypanosomiasis Research Institute cryobank for human and animal trypanosome isolates to support research: opportunities and challenges.
by: Grace A Murilla, et al.
Published: (2014)

"Piggy-backing" on diagnostic platforms brings hope to neglected diseases: the case of sleeping sickness.
by: Joseph Mathu Ndung'u, et al.
Published: (2010)

Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.
by: Natalia Tiberti, et al.
Published: (2013)

Knowledge, attitudes and practices about human African trypanosomiasis and their implications in designing intervention strategies for Yei county, South Sudan.
by: Salome A Bukachi, et al.
Published: (2018)

A mixed methods study of a health worker training intervention to increase syndromic referral for gambiense human African trypanosomiasis in South Sudan.
by: Jennifer J Palmer, et al.
Published: (2014)

Evidence of the absence of human African trypanosomiasis in two northern districts of Uganda: Analyses of cattle, pigs and tsetse flies for the presence of Trypanosoma brucei gambiense.
by: Lucas J Cunningham, et al.
Published: (2020)

Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency?
by: Epco Hasker, et al.
Published: (2012)